199
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Neuroprotective effect of alpha-lipoic acid and methylprednisolone on the spinal cord ischemia/reperfusion injury in rabbits

, , , , &
Pages 46-51 | Received 23 Oct 2012, Accepted 04 Aug 2014, Published online: 05 Sep 2014

References

  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.
  • Clark WM, Rinker LG, Lessov NS, Lowery SL, Cipolla MJ. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke 2001;32:1000–4.
  • Ersahin M, Toklu HZ, Cetinel S, et al. Alpha lipoic acid alleviates oxidative stress and preserves blood brain permeability in rats with subarachnoid hemorrhage. Neurochem Res 2010;35:418–28.
  • Dumont RJ, Okonkwo DO, Verma S, et al. Acute spinal cord injury,part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001;24:254–64.
  • Genovese T, Cuzzocrea S. Role of free radicals and poly (ADP-ribose) polymerase-1 in the development of spinal cord injury: new potential therapeutic targets. Curr Med Chem 2008; 15:477–87.
  • Junk AK, Mammis A, Savitz SI, et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 2002;99:10659–64.
  • Dolgun H, Sekerci Z, Turkoglu E, et al. Neuroprotective effect of mesna (2-mercaptoethane sulfonate) against spinal cord ischemia/reperfusion injury in rabbits. J Clin Neuroscience 2010;17:486–9.
  • Yılmaz ER, Kertmen H, Dolgun H, et al. Effects of darbepoetin-alpha in spinal cord ischemia-reperfusion injury in the rabbit. Acta Neurochir 2012;154:1037–44.
  • Chronidou F, Apostolakis E, Papapostolou I, et al. Beneficial effect of the oxygen free radical scavenger amifostine (WR-2721) on spinal cord ischemia/reperfusion injury in rabbits. J Cardiothorac Surg 2009;4:50.
  • Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997;29:315–31.
  • Shenk JC, Liu J, Fischbach K, et al. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J Neurol Sci 2009;283:199–206.
  • Hall ED, Vaishnav RA, Mustafa AG. Antioxidant therapies for traumatic brain injury. Neurotherapeutics 2010;7:51–61.
  • Morini M, Roccatagliata L, Dell’Eva R, et al. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. J Neuroimmunol 2004;148:146–53.
  • Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998;89:699–706.
  • Christie SD, Comeau B, Myers T, et al. Duration of lipid peroxidation after acute spinal cord injury in rats and the effect of methylprednisolone. Neurosurg Focus 2008;25:E5.
  • Saunders RD, Dugan LL, Demediuk P, et al. Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem 1987;49:24–31.
  • Emmez H, Yildirim Z, Kale A, et al. Anti-apoptotic and neuroprotective effects of alpha-lipoic acid on spinal cord ischemia-reperfusion injury in rabbits. Acta Neurochir 2010; 152:1591–601.
  • Tetik O, İslamoğlu F, Yagdi T, et al. An Intraaortic solution trial to prevent spinal cord injury in a rabbit model. Eur J Vasc Endovasc Surg 2001;22:175–9.
  • Hammouda A el-R, Khalil MM, Salem A. Lipid peroxidation products in pleural fluid for seperation of transudates and exudates. Clin Chem 1995;41:1314–5.
  • Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440–3.
  • Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497–500.
  • Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158–69.
  • Aebi H. Catalase in vitro. Enzymol 1984;105:121–6.
  • Kempski OS. Neuroprotection: models and basic principles. Anaesthesist 1994;43:25–33.
  • Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996;27:1124–9.
  • Kalkan E, Keskin F, Kaya B, et al. Effects of ilioprost and piracetem in spinal cord ischemia-reperfusion injury in the rabbit. Spinal Cord 2011;49:81–6.
  • Schmidley JW. Free radicals in central nervous system ischemia. Stroke 1990;21:1086–90.
  • Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 2004;11:1135–46.
  • Schillace RV, Pisenti N, Pattamanuch N, et al. Lipoic acid stimulates cAMP production in T lymphocytes and NK cells. Biochem Biophys Res Commun 2007;354:259–64.
  • Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997;22:359–78.
  • Bilska A, Wodek L. Lipoic acid – the drug of the future? Pharmacol Rep 2005;57:570–7.
  • Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev 2008;66:646–57.
  • Diaz-Ruiz A, Rios C, Duarte I, et al. Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone. Neuro Report 2000;11:1765–7.
  • Qian H, Liu D. The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography. Neurochem Res 1997;22:1231–6.
  • Erten SF, Kocak A, Ozdemir I, et al. Protective effect of melatonin on experimental spinal cord ischemia. Spinal Cord 2003;41:533–8.
  • Shaafi S, Afrooz Razm M, Hajipour B, et al. Anti-oxidative effect of lipoic acid in spinal cord ischemia/reperfusion. Med Princ Pract 2000;20:19–22.
  • Mates JM. Effects of antioxidant enzymes in the molecularcontrol of reactive oxygen species toxicology. Toxicology 2000;153:83–104.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.